The most common concern UK patients have about fat loss treatments in India is not safety or expertise — it is the technology. 'Are they using the same machines?' It is a fair question and it deserves a direct answer: yes. Here is the evidence.
This matters because non-surgical fat loss results are almost entirely device-dependent. CoolSculpting works because the Allergan machine delivers precisely calibrated cryolipolysis at -11 degrees Celsius. EMSculpt Neo works because BTL's HIFEM technology generates the specific electromagnetic frequency required for supramaximal muscle contractions. A different machine, even one that looks similar, would not deliver the same clinical outcomes. So the question of whether Indian clinics use the real devices is the right question.
Where Medical Devices Actually Come From
The manufacturers of the world's leading aesthetic devices are global companies that sell into all major markets. Allergan — maker of CoolSculpting — is a subsidiary of AbbVie, a multinational pharmaceutical company operating in over 175 countries. BTL Aesthetics — maker of EMSculpt Neo — sells its devices in over 85 countries and has a fully established commercial and service operation in India. Cynosure, InMode, Lumenis, Solta Medical, and Classys all have active commercial presences in India, with dedicated sales, training, and service infrastructure.
There is no 'Indian version' of these machines. There is no downgrade model sold to non-Western markets. The same device sold to a clinic in Harley Street in London is available to a JCI-accredited clinic in Gurugram, Delhi. The purchase process, the clinical training requirements, and the device specifications are identical.
India is not a peripheral market for these companies — it is a significant and growing one. The country's rapidly expanding affluent class, combined with a sophisticated private healthcare sector, has made it a commercially important destination for every major aesthetic device manufacturer.
The Specific Devices at Incostra's Partner Clinics
Rather than speaking in generalities, here is a direct account of the specific devices verified at Incostra's partner clinics in Delhi-NCR prior to our partnership:
All devices are verified at the point of clinic onboarding. Incostra does not partner with clinics using unverified or non-branded devices. Equipment documentation is available to patients on request prior to booking.
Why the Same Device Costs Less to Operate in India
If the machines are the same, why is the treatment cheaper? This is the right follow-up question.
The device purchase cost is the same or very similar globally — manufacturers do not significantly discount their technology for the Indian market. The difference in treatment cost comes entirely from what the clinic pays to run that device in Delhi versus London.
A Delhi JCI clinic can offer the same CoolSculpting session at £200 per area because its overhead structure is fundamentally different — not because it is cutting corners on equipment or clinical standards. The machine and the practitioner are equivalent. The property lease and the regulatory burden are not.
|
Want to see the exact devices at Incostra's partner clinics? Book a free consultation and we will walk you through the equipment in detail. Visit incostra.com/contact |
How to Verify Equipment Yourself
You should never take a clinic's word for it — including Incostra's. Here is how to verify independently that a clinic is using the genuine device:
Incostra proactively provides equipment verification documentation for all partner clinics to patients who request it. We believe informed patients make better decisions — and the evidence about our partner clinic devices is straightforwardly positive.
The Training Question — Are Indian Practitioners as Qualified?
Device quality and practitioner quality are separate questions. Having the right machine matters. Having a trained practitioner using it matters equally.
BTL and Allergan require certified training for all practitioners using their devices globally. This is not optional — it is a condition of device purchase and ongoing support. Practitioners at Delhi JCI clinics who operate EMSculpt Neo and CoolSculpting have completed the same manufacturer-mandated training programme as UK practitioners.
Beyond device certification, the practitioners at Incostra's partner clinics are board-certified dermatologists or plastic surgeons. In India, aesthetic treatments including fat loss procedures are typically performed by qualified medical doctors rather than nurses or aesthetic therapists, as is common in UK medspa settings. Many have completed additional training or fellowships in the UK, the US, or Europe.
Practitioner credentials for all Incostra partner doctors are verified as part of our onboarding process and are available to patients on request.
What JCI Accreditation Means for Technology Standards
The Joint Commission International is the global arm of the same body that accredits hospitals in the United States. JCI accreditation is among the most rigorous external quality audits a healthcare facility can undergo.
Crucially for patients considering aesthetic treatments, JCI accreditation specifically covers equipment maintenance, calibration, and safety protocols. A JCI-accredited clinic must maintain all devices to manufacturer standards and document that maintenance. This is independently verified by JCI auditors — it is not self-reported.
This means that when Incostra tells you a partner clinic is JCI-accredited, you have an independently verified guarantee that the devices are maintained to the standard required by Allergan, BTL, and Cynosure. The accreditation process would not permit a clinic to run out-of-calibration equipment.
A Direct Comparison — What You Are Getting in Delhi vs London
To be concrete about what equivalence means in practice:
The technology is the same. The clinical protocols are the same. The results timeline is the same. The practitioners are board-certified and manufacturer-certified. The bill is 60-80% lower. That gap is entirely explained by structural economics — not by any difference in clinical quality.